Craig Wilen, MD, PhD, received his A.B in Biology and Economics at Washington University in St. Louis, his MD and PhD from the University of Pennsylvania. His residency training was in clinical pathology at Barnes-Jewish Hospital in St. Louis, MO. His postdoctoral studies were conducted in the laboratory of Herbert "Skip" Virgin in the Department of Pathology & Immunology at Washington University School of Medicine where he discovered CD300lf as the first receptor for a norovirus and identified intestinal tuft cells as the physiologic target cell for mouse norovirus infection. Dr. Wilen is currently an Assistant Professor in Laboratory Medicine and Immunobiology. The Wilen lab studies how viruses, particularly coronaviruses and norovirus, interact with and evade the immune system. We use a variety of mouse and human models to identify the molecular mechanisms of viral pathogenesis with our long term goal being to leverage these basic science discoveries to develop affordable and effective vaccines and therapeutics.

@wilenlab